Eric Pauwels
Corporate Officer/Principal at PTC THERAPEUTICS, INC.
Net worth: 502 943 $ as of 2024-04-29
Network origin in Eric Pauwels first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 47 | |
| Subsidiary | Pharmaceuticals: Major | 31 | |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA.
14
| Subsidiary | Medical Specialties | 14 |
Bayer HealthCare Pharmaceuticals, Inc.
 Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Bayer HealthCare Pharmaceuticals, Inc. manufactures pharmaceutical drugs. It offers pharmaceuticals and therapeutics in the areas of diagnostic imaging, hematology and cardiology, cancer, women's health and several other chronic diseases such as multiple sclerosis and Parkinson's disease. Bayer HealthCare Pharmaceuticals was founded in 1979 and is located in Wayne, NJ.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Eric Pauwels via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| SHIRE | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal General Counsel Corporate Officer/Principal | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| PROTARA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Director of Finance/CFO Investor Relations Contact | |
Aventis Pharmaceuticals, Inc.
 Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO General Counsel | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal Graduate Degree | |
| UMass Chan Medical School | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
| Robert Wood Johnson Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal Graduate Degree | |
| University of Pennsylvania | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Sales & Marketing Corporate Officer/Principal | |
| PRAXIS PRECISION MEDICINES, INC. | Pharmaceuticals: Major | General Counsel Chief Executive Officer Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member Corporate Officer/Principal | |
| AMICUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer General Counsel Compliance Officer | |
| TRANSLATE BIO, INC. | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| Yale University | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| SAREPTA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Purdue University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Secretary | |
| Hoechst Marion Roussel, Inc. | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Director of Finance/CFO | ||
| GLOBAL BLOOD THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| BIOCRYST PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| ADVANCED ACCELERATOR APPLICATION SA(ADR) | Medical Specialties | Director/Board Member Director/Board Member | |
Shire Orphan Therapies GmbH
 Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| Weill Cornell Medical College | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| PREVAIL THERAPEUTICS INC. | Biotechnology | Chairman Human Resources Officer | |
| St. Anselm College | College/University | Director/Board Member Undergraduate Degree | |
| American University | College/University | Undergraduate Degree Undergraduate Degree | |
| New York University School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| Bucknell University | College/University | Director/Board Member Undergraduate Degree | |
| McGill University | College/University | Masters Business Admin Undergraduate Degree | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
Bayer Pharma AG
 Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| CYCLACEL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Yale College | College/University | Undergraduate Degree Undergraduate Degree | |
| CLEMENTIA PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Agilis Biotherapeutics LLC
 Agilis Biotherapeutics LLC BiotechnologyHealth Technology Agilis Biotherapeutics LLC operates as a biotechnology company. It focuses on designing and engineering first-in-class DNA-based therapeutics to improve and save the lives of patients affected by life-threatening or fatal rare diseases for which there are no or limited treatment options. The company was founded in 2013 and is headquartered in Cambridge, MA. | Biotechnology | Chief Executive Officer Corporate Officer/Principal |
Statistics
International
| United States | 44 |
| Germany | 3 |
| Canada | 3 |
| Ireland | 2 |
| France | 2 |
Sectoral
| Health Technology | 32 |
| Consumer Services | 16 |
| Commercial Services | 3 |
| Finance | 2 |
Operational
| Director/Board Member | 419 |
| Corporate Officer/Principal | 257 |
| Independent Dir/Board Member | 159 |
| Chairman | 82 |
| Undergraduate Degree | 72 |
Most connected contacts
| Insiders | |
|---|---|
| Glenn Steele | 54 |
| Pierre Legault | 45 |
| Jerome Zeldis | 38 |
| Georges Gemayel | 33 |
| Michael Bonney | 32 |
| Richard H. Aldrich | 31 |
| Robert Spiegel | 30 |
| Michael Schmertzler | 29 |
| Francois Nader | 28 |
| Adam Koppel | 26 |
| Sylvie Grégoire | 25 |
| Ronald Renaud | 24 |
| Susan Kelley | 22 |
| Luke Beshar | 19 |
| Dawn Svoronos | 19 |
- Stock Market
- Insiders
- Eric Pauwels
- Company connections
